Zur Kurzanzeige

2015-11-12Zeitschriftenartikel DOI: 10.2807/1560-7917.ES.2015.20.45.30062
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
dc.contributor.authorAlbiger, B.
dc.contributor.authorGlasner, C.
dc.contributor.authorStruelens, M. J.
dc.contributor.authorGrundmann, Hajo
dc.contributor.authorMonnet, D. L.
dc.contributor.authorEckmanns, Tim
dc.date.accessioned2018-05-07T18:34:42Z
dc.date.available2018-05-07T18:34:42Z
dc.date.created2015-11-20
dc.date.issued2015-11-12none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/re8XjAPSWtoo/PDF/29l6DKbWdy1U.pdf
dc.identifier.urihttp://edoc.rki.de/176904/2169
dc.description.abstractIn 2012, the European Centre for Disease Prevention and Control (ECDC) launched the ‘European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE)’ project to gain insights into the occurrence and epidemiology of carbapenemase-producing Enterobacteriaceae (CPE), to increase the awareness of the spread of CPE, and to build and enhance the laboratory capacity for diagnosis and surveillance of CPE in Europe. Data collected through a post-EuSCAPE feedback questionnaire in May 2015 documented improvement compared with 2013 in capacity and ability to detect CPE and identify the different carbapenemases genes in the 38 participating countries, thus contributing to their awareness of and knowledge about the spread of CPE. Over the last two years, the epidemiological situation of CPE worsened, in particular with the rapid spread of carbapenem-hydrolysing oxacillinase-48 (OXA-48)- and New Delhi metallo-beta-lactamase (NDM)-producing Enterobacteriaceae. In 2015, 13/38 countries reported inter-regional spread of or an endemic situation for CPE, compared with 6/38 in 2013. Only three countries replied that they had not identified one single case of CPE. The ongoing spread of CPE represents an increasing threat to patient safety in European hospitals, and a majority of countries reacted by establishing national CPE surveillances systems and issuing guidance on control measures for health professionals. However, 14 countries still lacked specific national guidelines for prevention and control of CPE in mid-2015.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subjectHumanseng
dc.subjectEurope/epidemiologyeng
dc.subjectBacterial Proteins/metabolismeng
dc.subjectMicrobial Sensitivity Testseng
dc.subjectAnti-Bacterial Agents/therapeutic useeng
dc.subjectbeta-Lactamases/metabolismeng
dc.subjectSurveys and Questionnaireseng
dc.subjectEnterobacteriaceae Infections/epidemiologyeng
dc.subjectEnterobacteriaceae Infections/microbiologyeng
dc.subjectEnterobacteriaceae/enzymologyeng
dc.subjectCarbapenems/therapeutic useeng
dc.subjectEnterobacteriaceae Infections/drug therapyeng
dc.subject.ddc610 Medizin
dc.titleCarbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10041551
dc.identifier.doi10.2807/1560-7917.ES.2015.20.45.30062
dc.identifier.doihttp://dx.doi.org/10.25646/2094
local.edoc.container-titleEuroSurveillance
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21300
local.edoc.container-publisher-nameECDC
local.edoc.container-volume20
local.edoc.container-issue45
local.edoc.container-year2015

Zur Kurzanzeige